34.3: Osmotic Diuretics
By the end of this section, you should be able to:
- 34.3.1 Identify the characteristics of osmotic diuretic drugs used for fluid volume excess and renal system disorders.
- 34.3.2 Explain the indications, actions, adverse reactions, and interactions of osmotic diuretic drugs used for fluid volume excess and renal system disorders.
- 34.3.3 Describe nursing implications of osmotic diuretic drugs used for fluid volume excess and renal system disorders.
- 34.3.4 Explain the client education related to osmotic diuretic drugs used for fluid volume excess and renal system disorders.
Osmotic diuretics decrease sodium and water reabsorption in the proximal tubule and the loop of Henle, increasing water loss. Mannitol, the primary osmotic diuretic, is typically used to treat increased intracranial and intraocular pressure.
Introduction and Use
Mannitol is a large sugar molecule that is readily filtered by the glomeruli and is not reabsorbed by the tubules. The resulting osmotic force increases the loss of sodium and water. Although mannitol is also approved to promote diuresis for acute renal failure and for excretion of toxic substances, it is used most commonly to treat increased intracranial pressure and increased intraocular pressure (Tenny et al., 2022). Mannitol reduces intracranial and intraocular pressures by moving water from the cells into the circulation. In the brain, mannitol creates an osmotic gradient that draws water across the blood–brain barrier. In the eye, mannitol draws water from the vitreous humor into the circulation, which decreases the pressure on the retina. Mannitol therapy requires close monitoring because of the risks for fluid volume excess, electrolyte imbalances, and adverse renal and neurologic effects of increased osmotic pressure.
Hypertonic saline solutions may be used in place of mannitol therapy because the saline solution does not cause hypovolemia in critically ill clients who may already be hypovolemic, hypotensive, or actively bleeding. There is some evidence that hypertonic saline solutions also improve cerebral perfusion and cellular oxygenation (Shi et al., 2020). In addition, in contrast to mannitol, the saline solution can be infused temporarily through a peripheral vein until central venous access is available, and it does not require special reconstitution or delivery systems. Moreover, the therapies are associated with similar clinical outcomes.
Adverse Effects and Contraindications
Mannitol, like other diuretics, can cause electrolyte abnormalities and dehydration. It can cause heart failure secondary to the rapid fluid shift of water into the intravascular space. Administration of the drug has also been associated with the development of AKI in clients with normal renal function. If warm temperatures are not maintained during administration, mannitol can precipitate into crystals, causing vascular and end-organ damage. It is also possible for leakage of mannitol across the blood–brain barrier to cause a rebound increase in intracranial pressure (Tenny et al., 2022).
The client’s kidney function must be adequate to manage the increased diuresis that mannitol will produce. It should be avoided in clients with anuria or previous renal damage caused by mannitol, and it should be used with caution in clients with decreased renal function. It should not be used for clients who are severely dehydrated or who have existing electrolyte abnormalities that could be exacerbated by its administration. Mannitol should not be used in clients with congestive heart failure or pulmonary edema.
Safety Alert
Osmotic Diuretics
Renal function should be monitored in all clients receiving mannitol. Acute renal failure can occur not only in clients with preexisting renal disease but also in clients with normal renal function.
(Source: DailyMed, Mannitol , 2023)
Table 34.4 is a drug prototype table for osmotic diuretics featuring mannitol. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.
|
Drug Class
Osmotic diuretic Mechanism of Action Increases osmotic pressure, which increases urinary output |
Drug Dosage
Increased intracranial pressure: Bolus injection of 0.25 g/kg IV every 6–8 hours as needed. Increased intraocular pressure: 0.25–2 g/kg IV of 20% solution over at least 30 minutes. |
|
Indications
Increased intracranial pressure Increased intraocular pressure Therapeutic Effects Relieves edema Increases urinary output |
Drug Interactions
Acetaminophen Acetylsalicylic acid (aspirin) Acyclovir Use with caution with all nephrotoxic drugs due to the cumulative effect. Food Interactions Alcohol Black licorice |
|
Adverse Effects
Hypokalemia Hyponatremia Orthostatic hypotension Hypovolemia Azotemia Oliguria Agranulocytosis Hyperuricemia Heart failure |
Contraindications
Hypersensitivity Anuria Severe hypovolemia Preexisting pulmonary edema Intracranial bleeding Congestive heart failure Impaired renal function Existing electrolyte abnormalities |
Nursing Implications
The nurse should do the following for clients who are taking mannitol:
- Administer the medication through a dedicated IV line in a large central vein (DailyMed, Mannitol , 2023).
- Use only filtered tubing to administer the medication (DailyMed, Mannitol , 2023).
- Avoid administering mannitol simultaneously with blood products.
- Check the medication vial for the presence of crystals. If they are present, warm the solution to 140ºF, vigorously agitate the vial, and then cool the medication to body temperature before administering (DailyMed, Mannitol , 2023).
- Monitor the infusion site for signs of extravasation during administration.
- Carefully monitor the client’s fluid volume status by assessing vital signs and weight.
- Monitor lung sounds for congestion and other signs of heart failure or circulatory overload.
- Monitor laboratory values for electrolyte imbalances.
- Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.
Clinical Tip
Mannitol Administration
Monitor the insertion site during the infusion for signs of extravasation because extravasation of mannitol can result in the development of compartment syndrome in the arm in which it is infusing. Compartment syndrome is a state of increased pressure in a closed compartment containing bone and fascia, resulting in tissue injury.
(Source: DailyMed, Mannitol , 2023)
Client Teaching Guidelines
The client taking an osmotic diuretic should:
- Avoid potential food interactions, including black licorice and alcohol.
- Report any pain, especially headaches or pain at the infusion site.
- Report changes in vision (in clients being treated for increased intraocular pressure).